Nonpathogenic Escherichia coli strain Nissle1917 prevents murine acute and chronic colitis. - Test2 - elhamkhani - TriplyDB

Nonpathogenic Escherichia coli strain Nissle1917 prevents murine acute and chronic colitis.

Nonpathogenic Escherichia coli strain Nissle1917 prevents murine acute and chronic colitis.

http://www.wikidata.org/entity/Q34415570

about

Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.Probiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens.Multiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4.Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.Clinical use of E. coli Nissle 1917 in inflammatory bowel disease.Distinct Commensals Induce Interleukin-1β via NLRP3 Inflammasome in Inflammatory Monocytes to Promote Intestinal Inflammation in Response to Injury Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity.Host and microbiota factors that control Klebsiella pneumoniae mucosal colonization in mice.Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.Impact of metal ion homeostasis of genetically modified Escherichia coli Nissle 1917 and K12 (W3110) strains on colonization properties in the murine intestinal tract.Rationale for probiotic treatment strategies in inflammatory bowel disease.Traditional Chinese Medicine QPYF as Preventive Treatment for Clostridium difficile Associated Diarrhea in a Mouse Model.Probiotic yogurt Affects Pro- and Anti-inflammatory Factors in Patients with Inflammatory Bowel Disease.Lessons from probiotic-host interaction studies in murine models of experimental colitis.Importance of IL-10 modulation by probiotic microorganisms in gastrointestinal inflammatory diseases.Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases.Impact of a probiotic Enterococcus faecalis in a gnotobiotic mouse model of experimental colitis.Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells.Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways.Live and heat-killed probiotic: effects on chronic experimental colitis induced by dextran sulfate sodium (DSS) in rats.The translocation kinetics of antibiotics through porin OmpC: insights from structure-based solvation mapping using WaterMap.Oral administration of taurolidine ameliorates chronic DSS colitis in mice.Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis.Effects of probiotic Lactobacillus rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS supplementation on intestinal and systemic markers of inflammation in ApoE*3Leiden mice consuming a high-fat diet.Bifidobacterium longum subsp. infantis BB-02 attenuates acute murine experimental model of inflammatory bowel disease.Crohn's disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin.Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integritiy of polarized intestinal epithelial cells.Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseases Commensal gut bacteria: distribution of Enterococcus species and prevalence of Escherichia coli phylogenetic groups in animals and humans in Portugal

P2860

Q33503647-0B39996B-1737-4FB5-A784-AB634627AC5B Q33639134-74D07525-62B2-4AC8-BEDA-100034939C56 Q33651733-F28456D6-EEC5-4549-8A5C-CDF6B87EE483 Q33684740-73EA9FD4-DD2C-49B5-A559-D1AB43FBE4EC Q34162963-9D7B1B93-FCAC-4044-AB28-78AB4D96DC96 Q34588415-4EFE1B96-7889-4B39-B11C-DD749ADEDCAC Q34744012-1614C7CF-A34E-4D7B-838D-F8023F3C2BE0 Q35533509-67CBB9B6-EE64-4538-8FF6-06F0F0835DEF Q35590543-D308C797-1ECA-43DD-815C-8952EF8FB0F7 Q36392065-FEE0A3F1-BB3B-4B49-BF5B-80869102D01D Q37079287-E7040048-F880-48C3-8D4A-4B08E5413EB9 Q37082773-6D5E6C42-6DB2-45B7-A762-111FE33D58B8 Q37320020-326459AF-337F-476E-8AFC-9833786691C8 Q37345932-36A09D23-DED4-47BD-822B-0FA6B3C9672A Q37483380-025C07B8-913B-4144-9441-8C147C22E2F5 Q37576939-6A34A0DF-FDED-440A-A66D-1281389A8D1E Q37907198-8EFE8CD4-8FC7-4EF3-936B-0FC418A080C8 Q38339037-29534DC1-04EA-4FE3-8F91-8DFA4956ED78 Q39127400-39D641FF-983F-4965-BEC4-DD68EC7429D9 Q39604749-EC9A1146-92FB-4E61-9DF7-4C0F1832235E Q40060675-82F30E9A-5EE7-42E5-A92F-97548B426C9C Q40264330-55356FAC-BC98-479E-B993-E064A4CCAB90 Q42134713-8A94FB0A-5287-4591-BE21-14E9ED8A17F5 Q45855155-148AB371-140D-4761-990C-BBE4BE00044E Q46922561-0179A94E-309D-44C7-AB7A-7CDCCF1BEA36 Q50454240-62A3F65C-D1EC-4BA2-9338-2C32F2A94769 Q50795525-127EE38F-8CAE-44B5-BE39-A7E054E3B6ED Q51035866-709E5FAF-2DAD-43C2-A15A-44C4F1DA1EF2 Q54425261-74EDDFDE-207F-4FCB-90B5-9160026B6002 Q54467599-DC7D7877-5B8B-4966-9790-790F13C72539 Q58694467-C1503F58-A712-4AEC-B1AB-6D03D506F88E Q58873697-4B2D5A4E-4EFA-478E-A66E-B7F470C291AF

P2860

Nonpathogenic Escherichia coli strain Nissle1917 prevents murine acute and chronic colitis.

http://www.wikidata.org/entity/Q34415570

description

2005 nî lūn-bûn

@nan

2005 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Nonpathogenic Escherichia coli ...... ine acute and chronic colitis.

@ast

Nonpathogenic Escherichia coli ...... ine acute and chronic colitis.

@en

Nonpathogenic Escherichia coli ...... ine acute and chronic colitis.

@nl

type

label

Nonpathogenic Escherichia coli ...... ine acute and chronic colitis.

@ast

Nonpathogenic Escherichia coli ...... ine acute and chronic colitis.

@en

Nonpathogenic Escherichia coli ...... ine acute and chronic colitis.

@nl

prefLabel

Nonpathogenic Escherichia coli ...... ine acute and chronic colitis.

@ast

Nonpathogenic Escherichia coli ...... ine acute and chronic colitis.

@en

Nonpathogenic Escherichia coli ...... ine acute and chronic colitis.

@nl

P1433

Q34415570-1FFE0882-69B4-4777-87BC-390C495312BE

P1476

Q34415570-161010EC-E6AB-4CA1-B196-E91D7EADA0DA

P2093

Q34415570-081F93DF-733C-4343-AA64-F006CC6BA727

Q34415570-13A8F8BD-2416-47EE-88B4-00D56E75213D

Q34415570-28D5181A-4F09-4BEB-AD7C-C03AFAFF99AC

Q34415570-38C6116D-6D5F-4608-984A-163E9AD24643

Q34415570-38CC991B-4344-4C56-AF4F-3C4F8779239A

Q34415570-4200EB12-D06D-421B-9847-826044A83686

Q34415570-6B3C7F6F-77AC-475A-BB79-2E34CF4376E8

Q34415570-72D65720-751F-48AD-9C3E-487812CC16F6

Q34415570-768EBCB3-1FE2-4066-A3B6-F53663D62861

Q34415570-BAF1E70D-F299-44A2-9FA7-3E61FDE2CED6

P2860

Q34415570-14364ECD-819A-4187-A30D-B9971E1AA628

Q34415570-20C35EED-0090-42AD-AD4D-AE3D082DE24E

Q34415570-3EFA375C-8438-4964-9E86-EDA7194F3D9A

Q34415570-4BDC53C5-19D5-4923-A323-B5AF5F5E15D0

Q34415570-4DE66915-393B-4C9E-A213-8624F9CE4AB5

Q34415570-502F397C-DB6B-4997-B5C8-1247375BCB0E

Q34415570-556D4803-E68C-49E5-9D7D-7E77EB776410

Q34415570-6741AD47-4547-4CF8-AC33-059E65453117

Q34415570-7279D53C-0820-4676-AA50-4894BDF85EFE

Q34415570-7BE8F0CC-F710-4B81-8E42-7560A9654A2A

P304

Q34415570-63352A70-D268-43AE-B2E9-A639B378EC09

P31

Q34415570-FD9C1F9F-CF4D-4757-BFF8-31F91C394963

P356

Q34415570-F30D0316-A2C5-466F-829E-0FDBEE032299

P433

Q34415570-926F499C-8E07-44EE-A203-6B08B1A074B2

P478

Q34415570-8C180E71-DD09-488A-B231-233D812C3D59

P50

Q34415570-73CBE1F8-2CF4-47C3-BA1C-342006A429A3

P577

Q34415570-1DF0C006-E3B2-46B6-B2F9-8B0F1AAB403E

P698

Q34415570-EA51785E-B02C-46C2-A291-C643E534CC58

P356

01.MIB.0000158158.55955.DE

P1433

Inflammatory Bowel Diseases

P1476

Nonpathogenic Escherichia coli ...... rine acute and chronic colitis

@en

P2093

Hiroshi Chinen

http://www.w3.org/2001/XMLSchema#string

Kanji Tsuchimoto

http://www.w3.org/2001/XMLSchema#string

Katsuyoshi Matsuoka

http://www.w3.org/2001/XMLSchema#string

Kyong Su Hong

http://www.w3.org/2001/XMLSchema#string

Nagamu Inoue

http://www.w3.org/2001/XMLSchema#string

Noriaki Watanabe

http://www.w3.org/2001/XMLSchema#string

Susumu Okamoto

http://www.w3.org/2001/XMLSchema#string

Tadakazu Hisamatsu

http://www.w3.org/2001/XMLSchema#string

Takaya Yamada

http://www.w3.org/2001/XMLSchema#string

Tatsuo Suzuki

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammatory Bowel Disease

Interleukin-10-deficient mice develop chronic enterocolitis

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

Double blind, placebo controlled trial of metronidazole in Crohn's disease.

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

P304

455-463

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.MIB.0000158158.55955.DE

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Nobuhiko Kamada

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15867585

http://www.w3.org/2001/XMLSchema#string